1. Home
  2. KRRO vs NVX Comparison

KRRO vs NVX Comparison

Compare KRRO & NVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$11.21

Market Cap

150.0M

Sector

Health Care

ML Signal

HOLD

Logo NOVONIX Limited American Depository Shares

NVX

NOVONIX Limited American Depository Shares

HOLD

Current Price

$0.58

Market Cap

144.3M

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRRO
NVX
Founded
2014
2012
Country
United States
Australia
Employees
N/A
192
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
150.0M
144.3M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
KRRO
NVX
Price
$11.21
$0.58
Analyst Decision
Buy
Analyst Count
12
0
Target Price
$34.80
N/A
AVG Volume (30 Days)
122.0K
308.4K
Earning Date
05-13-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,392,000.00
N/A
Revenue This Year
N/A
$3,904.19
Revenue Next Year
N/A
$91.72
P/E Ratio
N/A
N/A
Revenue Growth
181.46
N/A
52 Week Low
$5.20
$0.59
52 Week High
$55.89
$3.86

Technical Indicators

Market Signals
Indicator
KRRO
NVX
Relative Strength Index (RSI) 46.11 32.65
Support Level $10.81 N/A
Resistance Level $14.42 $0.75
Average True Range (ATR) 0.99 0.05
MACD -0.07 -0.01
Stochastic Oscillator 42.92 13.62

Price Performance

Historical Comparison
KRRO
NVX

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

About NVX NOVONIX Limited American Depository Shares

NOVONIX Ltd is a battery technology company developing and scaling materials and equipment critical to the lithium-ion battery supply chain. The company has three operating segments: Battery Materials: It develops and manufactures battery anode materials, ii) Battery Technology: It develops and manufactures battery cell testing equipment, performs consulting services and carries out research and development in battery development, and Graphite Exploration: It manages the maintenance and future development of Mount Dromedary natural graphite deposit. The majority of the company's revenue is derived from the Battery Technology segment. Geographically, the maximum revenue is derived from North America, followed by Asia, and Europe.

Share on Social Networks: